The challenge of acute coronary syndromes

Lancet

Volumn 353, Issue SUPPL.2, 1999, Pages 1-4

  Simoons, Maarten L ^a   Boersma, Eric ^a   Van Der Zwaan, Coen ^a   Deckers, Jaap W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART FAILURE; AMBULANCE; CORONARY CARE UNIT; EMERGENCY HEALTH SERVICE; FIBRINOLYTIC THERAPY; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; ST SEGMENT ELEVATION;

EID: 0033549340     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(99)90233-7     Document Type: Article

References (34)

1. Theroux P, Fusters V. Acute coronary syndromes. Unstable angina and non-Q wave myocardial infarction. Clinical cardiology: new frontiers. Circulation 1998; 97: 1195-206.
2. Day HW. An intensive coronary care area. Dis Chest 1963; 44: 423-27.
3. Brown KWG, McMillan RL, Borbath N, et al. Coronary care unit, an intensive care centre for acute myocardial infarction. Lancet 1963; i: 349-52.
4. Lown B, Fakhro AM, Hood WB, Thorn GW. The coronary care unit; new perspectives and directions. JAMA 1967; 199: 188-98.
5. Bloom BS, Peterson OL. End results, cost and productivity of coronary care units. N Engl J Med 1973; 288: 72-78.
6. Cobb LA, Baum RS, Alvarez III H, Schaffer WA. Resuscitation from out of hospital ventricular fibrillation: 4 year follow up. Circulation 1975; 51/52 (suppl III): 223-28.
7. Simoons ML, Serruys PW, Fopretti P, Brand M vd, Hugenholtz PG. Practical guidelines for treatment with beta blockers and nitrates in patients with acute myocardial infarction. Eur Heart J 1983; 4: 129-35.
8. HINT Research Group. Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Br Heart J 1986; 56: 400-13.
9. Simoons ML, Serruys PW, Brand M vd, et al. Improved survival after early thromboiysis in acute myocardial infarction. A randomized trial conducted by the Interuniversity Cardiology Institute in the Netherlands. Lancet 1985; ii: 578-82.
10. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
11. The Reperfusion Therapy Consensus Group. Factors that determine efficacy and applicability for reperfusion therapy in clinical practice: a search for consensus. Eur Heart J 1997; 18: 1371-81.
12. Durrer D, Lie KI,Wieken LR van der, et al. Results of a 24 hour day out-patient facility for acute cardiac diseases (Berste Hart Hulp) in Amsterdam. Proc Neth Acad Science 1979; 507-26.
13. Wackers FJT, School JB van der, Busemann E-Sokolo, et al. Noninvasive visualization of acute myocardial infarction in man with Thallium-201. Br Heart J 1975; 37: 741.
14. Fineberg HV, Scaddem D, Goldman L. Care of patients with a low probability of acute myocardial infarction. Cost effectiveness of alternatives to coronary care unit admission. N Engl J Med 1984; 310: 1301-07.
15. Roberts RR, Zelenski RJ, Mensah EK, et al. Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain: a randomized controlled trial. JAMA 1997; 278 (20): 1670-76.
16. Grijseels EWM, Deckers JW, Hoes AW, et al. Prehospital triage of patients with suspected acute myocardial infarction. Eur Heart J 1995; 16: 325-32.
17. Bouten MJM, Simoons ML, Hartman JAM, Van Miltenburg AJM, Van der Does E, Pool J, Prehospital thrombolysis with alteplase (rtPA) in acute myocardial infarction. Eur Heart J 1992; 13: 925-31.
18. Aufderheide TP, Kereiakes DJ, Weaver WD, Gibier WB, Simoons ML. Planning, implementation, and process monitoring for prehospital 12-lead ECG diagnostic programs. Prehosp Disaster Med 1996; 11 (3): 162-71.
19. Boersma E, Maas ACP, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348: 771-75.
20. The European Myocardial Infarction Project Group. Pre-hospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993; 329: 383-89.
21. Boersma H, Haas ACP, Grijseels EWN, Deckers JW, Hartman JAM, Simoons ML. Benefits and risks of possible prehospital thrombolysis strategies - the role of the electrocardiogram. Cardiologie 1998; 5: 562-68.
22. Simoons ML, Maggioni AP, Knatterud G, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet 1993; 342: 1523-528.
23. Simoons ML, Arnold AER. Tailored thrombolytic therapy. A perspective. Circulation 1993; 88: 2556-64.
24. Boersma E, Steyerberg EW, Vlugt van der MJ, Simoons ML. Reperfusion therapy for acute myocardial infarction: which strategy for which patients? Drugs 1998; 56 (1): 31-48.
25. Kong DF, Califf RM, Miller DP, et al. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischaemic heart disease. Circulation 1998; 98: 2829-35.
26. Ronner E, Dykun Y, Brand MJBM van den, Wieken LR van der, Simoons ML. Platelet glycoprotein IIb/IIIa receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention. Eur Heart J 1998; 19: 1608-16.
27. Lee KL, Woodlief LH, Topol EJ, et al, for the GUSTO investigators. Predictors of 30 day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41 021 patients. Circulation 1995; 91: 1659-68.
28. Holmvang L, Luscher MS, Clemmensen P,Thygesen K, Grande P. Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (a thrombin inhibition in myocardial ischaemia [TRIM] substudy). Circulation 1998; 98: 2004-09.
29. Geleijnse ML, Elhandy A, Kasprzak JD, et al. Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a nondiagnostic electrocardiogram. J Am Coll Cardiol 1998; 11: 606-11.
30. Armstrong PW, FuY, Chang WC, et al. Acute coronary syndromes in the GUSTO-IIb trial prognostic insights and impact of recurrent ischaemia. Ciculation 1998; 98: 1860-68.
31. Task Force of the Working Group on Exercise Physiology, Physiopathology and Electrocardiology. Eur J Heart 1993; 14: 969-88.
32. The Task Force on the management of acute myocardial infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 1996; 17: 43-63.
33. Wood D, Backer G de, Faergeman O, Graham I, Manicia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998; 19: 1434-503.
34. Simoons ML, Brand M van den, Lincoff M, et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J (in press).